Literature DB >> 30858300

Antibiotic Korormicin A Kills Bacteria by Producing Reactive Oxygen Species.

Nicole L Butler1,2, Takeshi Ito2, Adam Maynard3,2, Adilson José da Silva2,4,5, Masatoshi Murai6, Tsute Chen7,8, Mattheos A G Koffas3,2,4, Hideto Miyoshi6, Blanca Barquera9,2.   

Abstract

Korormicin is an antibiotic produced by some pseudoalteromonads which selectively kills Gram-negative bacteria that express the Na+-pumping NADH:quinone oxidoreductase (Na+-NQR.) We show that although korormicin is an inhibitor of Na+-NQR, the antibiotic action is not a direct result of inhibiting enzyme activity. Instead, perturbation of electron transfer inside the enzyme promotes a reaction between O2 and one or more redox cofactors in the enzyme (likely the flavin adenine dinucleotide [FAD] and 2Fe-2S center), leading to the production of reactive oxygen species (ROS). All Pseudoalteromonas contain the nqr operon in their genomes, including Pseudoalteromonas strain J010, which produces korormicin. We present activity data indicating that this strain expresses an active Na+-NQR and that this enzyme is not susceptible to korormicin inhibition. On the basis of our DNA sequence data, we show that the Na+-NQR of Pseudoalteromonas J010 carries an amino acid substitution (NqrB-G141A; Vibrio cholerae numbering) that in other Na+-NQRs confers resistance against korormicin. This is likely the reason that a functional Na+-NQR is able to exist in a bacterium that produces a compound that typically inhibits this enzyme and causes cell death. Korormicin is an effective antibiotic against such pathogens as Vibrio cholerae, Aliivibrio fischeri, and Pseudomonas aeruginosa but has no effect on Bacteroides fragilis and Bacteroides thetaiotaomicron, microorganisms that are important members of the human intestinal microflora.IMPORTANCE As multidrug antibiotic resistance in pathogenic bacteria continues to rise, there is a critical need for novel antimicrobial agents. An essential requirement for a useful antibiotic is that it selectively targets bacteria without significant effects on the eukaryotic hosts. Korormicin is an excellent candidate in this respect because it targets a unique respiratory enzyme found only in prokaryotes, the Na+-pumping NADH:quinone oxidoreductase (Na+-NQR). Korormicin is synthesized by some species of the marine bacterium Pseudoalteromonas and is a potent and specific inhibitor of Na+-NQR, an enzyme that is essential for the survival and proliferation of many Gram-negative human pathogens, including Vibrio cholerae and Pseudomonas aeruginosa, among others. Here, we identified how korormicin selectively kills these bacteria. The binding of korormicin to Na+-NQR promotes the formation of reactive oxygen species generated by the reaction of the FAD and the 2Fe-2S center cofactors with O2.
Copyright © 2019 American Society for Microbiology.

Entities:  

Keywords:  Na+-NQR; antibiotic; korormicin; reactive oxygen species

Mesh:

Substances:

Year:  2019        PMID: 30858300      PMCID: PMC6509656          DOI: 10.1128/JB.00718-18

Source DB:  PubMed          Journal:  J Bacteriol        ISSN: 0021-9193            Impact factor:   3.490


  37 in total

Review 1.  Recent progress in the Na(+)-translocating NADH-quinone reductase from the marine Vibrio alginolyticus.

Authors:  M Hayashi; Y Nakayama; T Unemoto
Journal:  Biochim Biophys Acta       Date:  2001-05-01

Review 2.  Oxidative stress.

Authors:  G Storz; J A Imlay
Journal:  Curr Opin Microbiol       Date:  1999-04       Impact factor: 7.934

3.  Korormicin, an antibiotic specific for gram-negative marine bacteria, strongly inhibits the respiratory chain-linked Na+-translocating NADH: quinone reductase from the marine Vibrio alginolyticus.

Authors:  K Yoshikawa; Y Nakayama; M Hayashi; T Unemoto; K Mochida
Journal:  J Antibiot (Tokyo)       Date:  1999-02       Impact factor: 2.649

4.  Expression and mutagenesis of the NqrC subunit of the NQR respiratory Na(+) pump from Vibrio cholerae with covalently attached FMN.

Authors:  B Barquera; C C Häse; R B Gennis
Journal:  FEBS Lett       Date:  2001-03-09       Impact factor: 4.124

5.  Purification and characterization of the recombinant Na(+)-translocating NADH:quinone oxidoreductase from Vibrio cholerae.

Authors:  Blanca Barquera; Petra Hellwig; Weidong Zhou; Joel E Morgan; Claudia C Häse; Khoosheh K Gosink; Mark Nilges; Peter J Bruesehoff; Annette Roth; C Roy D Lancaster; Robert B Gennis
Journal:  Biochemistry       Date:  2002-03-19       Impact factor: 3.162

6.  Inhibitor studies of a new antibiotic, korormicin, 2-n-heptyl-4-hydroxyquinoline N-oxide and Ag+ toward the Na+-translocating NADH-quinone reductase from the marine Vibrio alginolyticus.

Authors:  Y Nakayama; M Hayashi; K Yoshikawa; K Mochida; T Unemoto
Journal:  Biol Pharm Bull       Date:  1999-10       Impact factor: 2.233

7.  Riboflavin is a component of the Na+-pumping NADH-quinone oxidoreductase from Vibrio cholerae.

Authors:  Blanca Barquera; Weidong Zhou; Joel E Morgan; Robert B Gennis
Journal:  Proc Natl Acad Sci U S A       Date:  2002-07-16       Impact factor: 11.205

8.  The essential role of fumarate reductase in haem-dependent growth stimulation of Bacteroides fragilis.

Authors:  Anthony D Baughn; Michael H Malamy
Journal:  Microbiology       Date:  2003-06       Impact factor: 2.777

9.  FMN is covalently attached to a threonine residue in the NqrB and NqrC subunits of Na(+)-translocating NADH-quinone reductase from Vibrio alginolyticus.

Authors:  M Hayashi; Y Nakayama; M Yasui; M Maeda; K Furuishi; T Unemoto
Journal:  FEBS Lett       Date:  2001-01-12       Impact factor: 4.124

10.  Korormicin insensitivity in Vibrio alginolyticus is correlated with a single point mutation of Gly-140 in the NqrB subunit of the Na(+)-translocating NADH-quinone reductase.

Authors:  Maki Hayashi; Naoaki Shibata; Yuji Nakayama; Kazuhiro Yoshikawa; Tsutomu Unemoto
Journal:  Arch Biochem Biophys       Date:  2002-05-15       Impact factor: 4.013

View more
  5 in total

Review 1.  Expanding the search for small-molecule antibacterials by multidimensional profiling.

Authors:  Karin Ortmayr; Roberto de la Cruz Moreno; Mattia Zampieri
Journal:  Nat Chem Biol       Date:  2022-05-23       Impact factor: 16.174

2.  Inhibitors of a Na+-pumping NADH-ubiquinone oxidoreductase play multiple roles to block enzyme function.

Authors:  Takahiro Masuya; Yuki Sano; Hinako Tanaka; Nicole L Butler; Takeshi Ito; Tatsuhiko Tosaki; Joel E Morgan; Masatoshi Murai; Blanca Barquera; Hideto Miyoshi
Journal:  J Biol Chem       Date:  2020-07-20       Impact factor: 5.157

3.  Molecular dynamics modeling of the Vibrio cholera Na+-translocating NADH:quinone oxidoreductase NqrB-NqrD subunit interface.

Authors:  Alexander Dibrov; Muntahi Mourin; Pavel Dibrov; Grant N Pierce
Journal:  Mol Cell Biochem       Date:  2021-10-09       Impact factor: 3.396

4.  Cryo-EM structures of Na+-pumping NADH-ubiquinone oxidoreductase from Vibrio cholerae.

Authors:  Jun-Ichi Kishikawa; Moe Ishikawa; Takahiro Masuya; Masatoshi Murai; Yuki Kitazumi; Nicole L Butler; Takayuki Kato; Blanca Barquera; Hideto Miyoshi
Journal:  Nat Commun       Date:  2022-07-26       Impact factor: 17.694

5.  Potential toxicity of leachate from the municipal landfill in view of the possibility of their migration to the environment through infiltration into groundwater.

Authors:  Agata Jabłońska-Trypuć; Urszula Wydro; Elżbieta Wołejko; Anna Pietryczuk; Adam Cudowski; Jacek Leszczyński; Joanna Rodziewicz; Wojciech Janczukowicz; Andrzej Butarewicz
Journal:  Environ Geochem Health       Date:  2021-03-06       Impact factor: 4.609

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.